Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ALPN |
---|---|---|
09:32 ET | 37409 | 64.96 |
09:34 ET | 66050 | 64.96 |
09:36 ET | 293314 | 64.945 |
09:38 ET | 18202 | 64.945 |
09:39 ET | 12540 | 64.945 |
09:41 ET | 18217 | 64.95 |
09:43 ET | 57893 | 64.94 |
09:45 ET | 2800 | 64.95 |
09:48 ET | 22827 | 64.95 |
09:50 ET | 21078 | 64.94 |
09:52 ET | 500 | 64.94 |
09:54 ET | 6646 | 64.95 |
09:56 ET | 5550 | 64.94 |
09:57 ET | 3715 | 64.94 |
09:59 ET | 800 | 64.94 |
10:01 ET | 3924 | 64.945 |
10:03 ET | 570 | 64.95 |
10:06 ET | 1100 | 64.94 |
10:08 ET | 300 | 64.95 |
10:10 ET | 1241 | 64.945 |
10:12 ET | 500 | 64.945 |
10:14 ET | 500 | 64.95 |
10:15 ET | 2600 | 64.945 |
10:17 ET | 998 | 64.945 |
10:19 ET | 600 | 64.945 |
10:21 ET | 2579 | 64.945 |
10:24 ET | 12830 | 64.945 |
10:26 ET | 100 | 64.95 |
10:28 ET | 400 | 64.94 |
10:30 ET | 500 | 64.94 |
10:32 ET | 400 | 64.94 |
10:33 ET | 1000 | 64.94 |
10:35 ET | 700 | 64.94 |
10:37 ET | 400 | 64.94 |
10:39 ET | 700 | 64.94 |
10:42 ET | 1670 | 64.95 |
10:44 ET | 400 | 64.94 |
10:46 ET | 800 | 64.94 |
10:48 ET | 300 | 64.94 |
10:50 ET | 432 | 64.94 |
10:51 ET | 400 | 64.94 |
10:53 ET | 900 | 64.94 |
10:55 ET | 3790 | 64.95 |
10:57 ET | 3124 | 64.95 |
11:00 ET | 700 | 64.95 |
11:02 ET | 19730 | 64.95 |
11:04 ET | 1479 | 64.94 |
11:06 ET | 2184 | 64.95 |
11:08 ET | 8489 | 64.95 |
11:09 ET | 93025 | 64.945 |
11:11 ET | 1329 | 64.95 |
11:13 ET | 1965 | 64.94 |
11:15 ET | 4285 | 64.945 |
11:18 ET | 23430 | 64.945 |
11:20 ET | 1836 | 64.95 |
11:22 ET | 3773 | 64.945 |
11:24 ET | 700 | 64.95 |
11:26 ET | 1800 | 64.945 |
11:27 ET | 632 | 64.95 |
11:29 ET | 1100 | 64.95 |
11:31 ET | 1200 | 64.945 |
11:33 ET | 800 | 64.94 |
11:36 ET | 8400 | 64.95 |
11:38 ET | 1900 | 64.945 |
11:40 ET | 7533 | 64.95 |
11:42 ET | 100 | 64.95 |
11:44 ET | 400 | 64.9425 |
11:45 ET | 5211 | 64.95 |
11:47 ET | 7610 | 64.95 |
11:49 ET | 400 | 64.945 |
11:51 ET | 7100 | 64.945 |
11:54 ET | 1264 | 64.95 |
11:56 ET | 100 | 64.95 |
11:58 ET | 2000 | 64.945 |
12:00 ET | 500 | 64.945 |
12:02 ET | 3474 | 64.95 |
12:03 ET | 1400 | 64.945 |
12:05 ET | 6729 | 64.94 |
12:07 ET | 500 | 64.95 |
12:09 ET | 6362 | 64.95 |
12:12 ET | 33271 | 64.945 |
12:14 ET | 2200 | 64.95 |
12:16 ET | 400 | 64.945 |
12:18 ET | 900 | 64.95 |
12:20 ET | 7880 | 64.95 |
12:21 ET | 1709 | 64.95 |
12:23 ET | 7248 | 64.95 |
12:25 ET | 1050 | 64.95 |
12:27 ET | 800 | 64.95 |
12:30 ET | 2000 | 64.95 |
12:32 ET | 519 | 64.95 |
12:34 ET | 300 | 64.95 |
12:38 ET | 737 | 64.945 |
12:39 ET | 6192 | 64.95 |
12:41 ET | 1821 | 64.95 |
12:43 ET | 100 | 64.95 |
12:45 ET | 16974 | 64.95 |
12:48 ET | 200 | 64.95 |
12:50 ET | 700 | 64.95 |
12:52 ET | 100 | 64.95 |
12:54 ET | 762 | 64.95 |
12:56 ET | 300 | 64.95 |
12:57 ET | 863 | 64.945 |
12:59 ET | 500 | 64.95 |
01:01 ET | 16472 | 64.955 |
01:03 ET | 200 | 64.96 |
01:06 ET | 1700 | 64.955 |
01:08 ET | 500 | 64.955 |
01:10 ET | 193 | 64.955 |
01:12 ET | 200 | 64.96 |
01:14 ET | 300 | 64.96 |
01:15 ET | 200 | 64.96 |
01:17 ET | 3656 | 64.955 |
01:19 ET | 1000 | 64.95 |
01:21 ET | 810 | 64.95 |
01:24 ET | 1085 | 64.96 |
01:26 ET | 1400 | 64.96 |
01:28 ET | 897 | 64.955 |
01:30 ET | 3791 | 64.95 |
01:32 ET | 1800 | 64.96 |
01:33 ET | 200 | 64.96 |
01:35 ET | 500 | 64.95 |
01:37 ET | 782 | 64.95 |
01:39 ET | 200 | 64.96 |
01:42 ET | 200 | 64.96 |
01:44 ET | 547 | 64.96 |
01:46 ET | 700 | 64.95 |
01:48 ET | 100 | 64.96 |
01:50 ET | 3466 | 64.955 |
01:51 ET | 900 | 64.955 |
01:53 ET | 563 | 64.955 |
01:55 ET | 100 | 64.96 |
01:57 ET | 300 | 64.96 |
02:00 ET | 1569 | 64.96 |
02:02 ET | 10528 | 64.955 |
02:04 ET | 1713 | 64.96 |
02:06 ET | 718 | 64.955 |
02:08 ET | 1897 | 64.955 |
02:09 ET | 2800 | 64.955 |
02:11 ET | 100 | 64.955 |
02:13 ET | 1800 | 64.955 |
02:15 ET | 4557 | 64.955 |
02:18 ET | 300 | 64.96 |
02:20 ET | 100 | 64.96 |
02:22 ET | 100 | 64.96 |
02:24 ET | 200 | 64.96 |
02:26 ET | 1495 | 64.96 |
02:27 ET | 300 | 64.96 |
02:29 ET | 4557 | 64.955 |
02:31 ET | 100 | 64.96 |
02:33 ET | 2668 | 64.95 |
02:36 ET | 100 | 64.955 |
02:38 ET | 1500 | 64.96 |
02:40 ET | 1192 | 64.96 |
02:42 ET | 455 | 64.955 |
02:44 ET | 900 | 64.96 |
02:45 ET | 1310 | 64.96 |
02:47 ET | 100 | 64.96 |
02:49 ET | 300 | 64.95 |
02:51 ET | 200 | 64.955 |
02:54 ET | 1800 | 64.955 |
02:56 ET | 2378 | 64.955 |
02:58 ET | 1190 | 64.96 |
03:00 ET | 800 | 64.96 |
03:02 ET | 200 | 64.96 |
03:03 ET | 400 | 64.96 |
03:05 ET | 786 | 64.96 |
03:07 ET | 200 | 64.96 |
03:09 ET | 200 | 64.96 |
03:12 ET | 1350 | 64.96 |
03:14 ET | 200 | 64.95 |
03:16 ET | 100 | 64.955 |
03:18 ET | 600 | 64.96 |
03:20 ET | 1442 | 64.955 |
03:21 ET | 3400 | 64.95 |
03:23 ET | 1092 | 64.95 |
03:25 ET | 887 | 64.955 |
03:27 ET | 1681 | 64.96 |
03:30 ET | 200 | 64.96 |
03:32 ET | 542 | 64.96 |
03:34 ET | 1000 | 64.96 |
03:36 ET | 920 | 64.955 |
03:38 ET | 10326 | 64.96 |
03:39 ET | 295 | 64.96 |
03:41 ET | 300 | 64.96 |
03:43 ET | 3086 | 64.96 |
03:45 ET | 2503 | 64.96 |
03:48 ET | 1400 | 64.955 |
03:50 ET | 600 | 64.96 |
03:52 ET | 5819 | 64.96 |
03:54 ET | 400 | 64.96 |
03:56 ET | 18714 | 64.96 |
03:57 ET | 11623 | 64.96 |
03:59 ET | 28056 | 64.97 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Alpine Immune Sciences Inc | 4.5B | -95.0x | --- |
Krystal Biotech Inc | 4.7B | 86.7x | --- |
Immunovant Inc | 4.5B | -16.9x | --- |
Madrigal Pharmaceuticals Inc | 4.5B | -9.2x | --- |
Nuvalent Inc | 4.6B | -29.7x | --- |
Crinetics Pharmaceuticals Inc | 4.0B | -13.4x | --- |
Alpine Immune Sciences, Inc. is a clinical-stage biopharmaceutical company, which is engaged in discovering and developing protein-based immunotherapies to treat autoimmune and inflammatory diseases. The Company’s approach includes a proprietary scientific platform that converts native immune system proteins into differentiated, multi-targeted therapeutics. Its ALPN-303 (povetacicept) is a dual antagonist of the B cell activating factor (BAFF) and a proliferation, inducing ligand (APRIL), cytokines, which play key roles in the pathogenesis of multiple autoimmune diseases via their contribution to the activation, differentiation and/or survival of B cells, particularly antibody-secreting cells, as well as T cells and innate immune cells. Its ALPN-101 (acazicolcept) is a dual Inducible T cell Costimulator (ICOS), and CD28 antagonist intended for the treatment of autoimmune and inflammatory diseases.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.5B |
---|---|
Revenue (TTM) | $56.5M |
Shares Outstanding | 68.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.84 |
EPS | $-0.68 |
Book Value | $5.43 |
P/E Ratio | -95.0x |
Price/Sales (TTM) | 78.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -90.86% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.